Maverick Biomaterials is continuing to advance its IP portfolio with regard to 3 Dimensional (3D) fixation of specifically sourced raw pericardium from it supplier Maverick Biosciences.
Recent production for a range of global clients has been well received, with Maverick Biomaterials defining a number of improvements available as production volumes increase.
Real purpose, real global impact: How Tania Fitzsimons found her greatest opportunity in her own backyard As a flight attendant, Tania Fitzsimons travelled the world: Japan, Germany, Africa, the United States … the impressive list goes on. Yet, south-east Queensland...
From farm life to saving lives: How hard-working mum Nikki Allwell became a leader at our global operation Nikki Allwell is a true blue roll-up-your-sleeves, get-the-job-done kind of person. As a mother raising a young family while working on a farm, she had to be....
Real global impact: How Dylan Pope is shaping his incredible R&D career in the place he least expectedDylan Pope is a driven young chemist who pushes for better every day. Joining Maverick Bio as a Production Technician, he immediately identified the need for a...
An unexpected career: James Gallagher found his great opportunity at #teammaverick - are you ready for yours?Born and bred in Dubbo, James Gallagher had never heard of Maverick Bio. The IT student had relocated to Canberra for his studies, but a reassessment of his...
9th February 2012. Maverick Biomaterials was today awarded ISO 13485:2003 certified by BSI, valid to 8th February 2015.
Subsequent to a recent AQIS Audit Maverick has been granted Intermediate Products listing to the EU. Approval was granted 25th January 2012.